C. H. Cabell

803 total citations
15 papers, 529 citations indexed

About

C. H. Cabell is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, C. H. Cabell has authored 15 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Surgery. Recurrent topics in C. H. Cabell's work include Infective Endocarditis Diagnosis and Management (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Streptococcal Infections and Treatments (6 papers). C. H. Cabell is often cited by papers focused on Infective Endocarditis Diagnosis and Management (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Streptococcal Infections and Treatments (6 papers). C. H. Cabell collaborates with scholars based in United States, Spain and France. C. H. Cabell's co-authors include Vance G. Fowler, G. Ralph Corey, Vivian H. Chu, José M. Miró, Daniel J. Sexton, Gilbert Habib, Bruno Hoen, Lars Olaison, Martín E. Stryjewski and Elías Abrutyn and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and The American Journal of Gastroenterology.

In The Last Decade

C. H. Cabell

15 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. H. Cabell United States 9 359 353 212 139 101 15 529
Tatjana Lejko-Zupanc Slovenia 10 249 0.7× 315 0.9× 112 0.5× 60 0.4× 57 0.6× 20 416
Cláudio Querido Fortes Brazil 12 448 1.2× 655 1.9× 253 1.2× 119 0.9× 179 1.8× 16 752
Martha Kestler Spain 12 246 0.7× 380 1.1× 114 0.5× 63 0.5× 63 0.6× 29 508
Marta Hernández‐Meneses Spain 13 200 0.6× 348 1.0× 142 0.7× 37 0.3× 143 1.4× 35 471
Laurel Gibbs United States 9 202 0.6× 89 0.3× 134 0.6× 99 0.7× 81 0.8× 10 434
Massimo Crapis Italy 12 284 0.8× 318 0.9× 123 0.6× 93 0.7× 73 0.7× 35 590
Dorte A. Wandall Denmark 6 173 0.5× 222 0.6× 116 0.5× 69 0.5× 42 0.4× 10 308
Gary R. Kravitz United States 10 182 0.5× 137 0.4× 83 0.4× 103 0.7× 30 0.3× 14 434
Sabine Gill Denmark 10 154 0.4× 245 0.7× 101 0.5× 56 0.4× 161 1.6× 26 403
Anita LaSala United States 6 291 0.8× 99 0.3× 164 0.8× 178 1.3× 45 0.4× 10 497

Countries citing papers authored by C. H. Cabell

Since Specialization
Citations

This map shows the geographic impact of C. H. Cabell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. H. Cabell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. H. Cabell more than expected).

Fields of papers citing papers by C. H. Cabell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. H. Cabell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. H. Cabell. The network helps show where C. H. Cabell may publish in the future.

Co-authorship network of co-authors of C. H. Cabell

This figure shows the co-authorship network connecting the top 25 collaborators of C. H. Cabell. A scholar is included among the top collaborators of C. H. Cabell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. H. Cabell. C. H. Cabell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Chiorean, Michael, Séverine Vermeire, Julián Panés, et al.. (2019). 764 Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study. The American Journal of Gastroenterology. 114(1). S445–S446. 2 indexed citations
3.
4.
Peyrin‐Biroulet, Laurent, Julián Panés, Michael Chiorean, et al.. (2019). 1006 – Histologic Remission and Mucosal Healing in a Randomized, Placebo-Controlled, Phase 2 Study of Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis. Gastroenterology. 156(6). S–217. 5 indexed citations
5.
6.
Kanafani, Zeina A., Souha S. Kanj, C. H. Cabell, et al.. (2010). Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. European Journal of Clinical Microbiology & Infectious Diseases. 29(10). 1203–1210. 42 indexed citations
7.
Eisen, Damon P., G. Ralph Corey, Emma S. McBryde, et al.. (2009). Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. Journal of Infection. 58(5). 332–338. 29 indexed citations
8.
Liao, Lawrence, David F. Kong, Zainab Samad, et al.. (2007). Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis. Heart. 94(5). e18–e18. 8 indexed citations
9.
Cabell, C. H., et al.. (2005). Aortic Coarctation Endarteritis in an Adult: Case Report with Cardiovascular Magnetic Resonance Imaging Findings and Review of the Literature. Clinical Infectious Diseases. 40(4). e28–e31. 9 indexed citations
10.
Anderson, Deverick J., Lars Olaison, Jay R. McDonald, et al.. (2005). Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. European Journal of Clinical Microbiology & Infectious Diseases. 24(10). 665–670. 40 indexed citations
11.
Stryjewski, Martín E., W. O'Riordan, William K. Lau, et al.. (2005). Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria. Clinical Infectious Diseases. 40(11). 1601–1607. 146 indexed citations
12.
Chu, Vivian H., C. H. Cabell, José M. Miró, et al.. (2005). Reply to Shah. Clinical Infectious Diseases. 40(11). 1704–1705. 1 indexed citations
13.
Chirouze, Catherine, C. H. Cabell, Vance G. Fowler, et al.. (2004). Prognostic Factors in 61 Cases of Staphylococcus aureus Prosthetic Valve Infective Endocarditis from the International Collaboration on Endocarditis Merged Database. Clinical Infectious Diseases. 38(9). 1323–1327. 92 indexed citations
14.
Anderson, Deverick J., David Murdoch, Daniel J. Sexton, et al.. (2004). Risk Factors for Infective Endocarditis in Patients with Enterococcal Bacteremia: A Case-Control Study. Infection. 32(2). 72–77. 58 indexed citations
15.
Chu, Vivian H., C. H. Cabell, Elías Abrutyn, et al.. (2004). Native Valve Endocarditis Due to Coagulase-Negative Staphylococci: Report of 99 Episodes from the International Collaboration on Endocarditis Merged Database. Clinical Infectious Diseases. 39(10). 1527–1530. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatjana Lejko-Zupanc Breakdown of academic impact, for papers by Cláudio Querido Fortes Breakdown of academic impact, for papers by Martha Kestler Breakdown of academic impact, for papers by Marta Hernández‐Meneses Breakdown of academic impact, for papers by Laurel Gibbs Breakdown of academic impact, for papers by Massimo Crapis Breakdown of academic impact, for papers by Dorte A. Wandall Breakdown of academic impact, for papers by Gary R. Kravitz Breakdown of academic impact, for papers by Sabine Gill Breakdown of academic impact, for papers by Anita LaSala
Rankless by CCL
2026